BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
VEGFA
,
Metabolism of xenobiotics
,
Pseudomonas infection
,
Intestine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
delta like ligand 4
Summary
General Info
Curated Studies
Most Correlated Studies
Eye imaginal discs from L3 larvae overexpressing Delta, lola, and pipsqueak
LMP1 TES2-mediated expression in HEK293 cells with and without IkBalpha super-repressor
Explore Curated Studies Results
Literature
Most Relevant Literature
GC-Globulin/Vitamin D-Binding Protein Is Required for Pancreatic α-Cell Adaptation to Metabolic Stre…
Vitamin D and Vitamin D-Binding Protein in Health and Disease.
Delta-Like Protein 3 Expression and Targeting in Merkel Cell Carcinoma.
Potential prognostic value of delta-like protein 3 in small cell lung cancer: a meta-analysis.
Vitamin D binding protein polymorphism and COVID-19.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)
A Study to Test How Well Different Doses of BI 764532 in Combination With Ezabenlimab Are Tolerated …
A Study of Tarlatamab in Participants With Neuroendocrine Prostate Cancer
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-t…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ